Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Georgescu C, Corbin JM, Thibivilliers S, Webb ZD, Zhao YD, Koster J, Fung KM, Asch AS, Wren JD, Ruiz-Echevarría MJ.

BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.

2.

Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.

Rao CV, Farooqui M, Asch AS, Yamada HY.

Cell Cycle. 2018;17(19-20):2321-2334. doi: 10.1080/15384101.2018.1515554. Epub 2018 Sep 20.

3.

Spontaneous development of Alzheimer's disease-associated brain pathology in a Shugoshin-1 mouse cohesinopathy model.

Rao CV, Farooqui M, Zhang Y, Asch AS, Yamada HY.

Aging Cell. 2018 Aug;17(4):e12797. doi: 10.1111/acel.12797. Epub 2018 Jun 25.

4.

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.

Rao CV, Pal S, Mohammed A, Farooqui M, Doescher MP, Asch AS, Yamada HY.

Oncotarget. 2017 May 10;8(34):57605-57621. doi: 10.18632/oncotarget.17745. eCollection 2017 Aug 22. Review.

5.

Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice.

Janakiram NB, Mohammed A, Bryant T, Ritchie R, Stratton N, Jackson L, Lightfoot S, Benbrook DM, Asch AS, Lang ML, Rao CV.

Immunology. 2017 Sep;152(1):36-51. doi: 10.1111/imm.12746. Epub 2017 May 29.

6.

Immunoprevention of Pancreatic Cancer.

Rao CV, Mohammed A, Asch AS, Janakiram NB.

Curr Med Chem. 2018;25(22):2576-2584. doi: 10.2174/0929867324666170223153509. Review.

PMID:
28240168
7.

Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer.

Mohammed A, Janakiram NB, Madka V, Li M, Asch AS, Rao CV.

Curr Med Chem. 2018;25(22):2535-2544. doi: 10.2174/0929867324666170209104453. Review.

PMID:
28183260
8.

Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

Rao CV, Asch AS, Yamada HY.

Carcinogenesis. 2017 Jan;38(1):2-11. doi: 10.1093/carcin/bgw118. Epub 2016 Nov 12. Review.

9.

Emerging links among Chromosome Instability (CIN), cancer, and aging.

Rao CV, Asch AS, Yamada HY.

Mol Carcinog. 2017 Mar;56(3):791-803. doi: 10.1002/mc.22539. Epub 2016 Aug 30. Review.

PMID:
27533343
10.

A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma.

Park SI, Grover NS, Olajide O, Asch AS, Wall JG, Richards KL, Sobol AL, Deal AM, Ivanova A, Foster MC, Muss HB, Shea TC.

Br J Haematol. 2016 Oct;175(2):281-289. doi: 10.1111/bjh.14232. Epub 2016 Jul 22.

11.

Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification.

Kobet RA, Pan X, Zhang B, Pak SC, Asch AS, Lee MH.

Biomol Ther (Seoul). 2014 Sep;22(5):371-83. doi: 10.4062/biomolther.2014.084. Epub 2014 Sep 30. Review.

12.

Role of PUF-8/PUF protein in stem cell control, sperm-oocyte decision and cell fate reprogramming.

Datla US, Scovill NC, Brokamp AJ, Kim E, Asch AS, Lee MH.

J Cell Physiol. 2014 Oct;229(10):1306-11. doi: 10.1002/jcp.24618. Review.

PMID:
24638209
13.

The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.

Chen X, Corbin JM, Tipton GJ, Yang LV, Asch AS, Ruiz-Echevarría MJ.

Biochim Biophys Acta. 2014 Jun;1843(6):1216-24. doi: 10.1016/j.bbamcr.2014.03.005. Epub 2014 Mar 13.

14.

TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.

Green T, Chen X, Ryan S, Asch AS, Ruiz-Echevarría MJ.

Prostate. 2013 Oct;73(14):1561-75. doi: 10.1002/pros.22706. Epub 2013 Jul 3.

15.

Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis.

Dong L, Li Z, Leffler NR, Asch AS, Chi JT, Yang LV.

PLoS One. 2013 Apr 16;8(4):e61991. doi: 10.1371/journal.pone.0061991. Print 2013.

16.

Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2.

Overcash RF, Chappell VA, Green T, Geyer CB, Asch AS, Ruiz-Echevarría MJ.

PLoS One. 2013;8(2):e55257. doi: 10.1371/journal.pone.0055257. Epub 2013 Feb 6.

17.

Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway.

Chen A, Dong L, Leffler NR, Asch AS, Witte ON, Yang LV.

PLoS One. 2011;6(11):e27586. doi: 10.1371/journal.pone.0027586. Epub 2011 Nov 16.

18.

Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.

Whelan JT, Hollis SE, Cha DS, Asch AS, Lee MH.

J Cell Physiol. 2012 Mar;227(3):1235-41. doi: 10.1002/jcp.22899. Review.

PMID:
21688267
19.

The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.

Chen X, Overcash R, Green T, Hoffman D, Asch AS, Ruiz-Echevarría MJ.

J Biol Chem. 2011 May 6;286(18):16091-100. doi: 10.1074/jbc.M110.193805. Epub 2011 Mar 10.

20.

Role of benzo[alpha]pyrene in generation of clustered DNA damage in human breast tissue.

Sigounas G, Hairr JW, Cooke CD, Owen JR, Asch AS, Weidner DA, Wiley JE.

Free Radic Biol Med. 2010 Jul 1;49(1):77-87. doi: 10.1016/j.freeradbiomed.2010.03.018. Epub 2010 Mar 25.

PMID:
20347033
21.

Rituximab in the treatment of acquired factor VIII inhibitors.

Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, Weksler BB, Schechter GP.

Blood. 2002 Nov 1;100(9):3426-8.

PMID:
12384448
22.

A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation.

Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T, Asch AS.

Nat Med. 2001 Jul;7(7):840-6.

PMID:
11433350
23.

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL.

J Clin Invest. 2001 Jan;107(1):45-52.

24.

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA.

Nature. 1998 Jan 1;391(6662):86-9. Erratum in: Nature 1998 Mar 12;392(6672):210. Gerhengorn MC [corrected to Gershengorn MC].

PMID:
9422510
26.

Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.

Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS.

J Exp Med. 1996 May 1;183(5):2385-90.

27.

Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices.

Rafii S, Oz MC, Seldomridge JA, Ferris B, Asch AS, Nachman RL, Shapiro F, Rose EA, Levin HR.

Ann Thorac Surg. 1995 Dec;60(6):1627-32.

PMID:
8787455
28.

Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors.

Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman RL, Moore MA, Asch AS.

Blood. 1995 Nov 1;86(9):3353-63.

PMID:
7579438
29.
30.

Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion.

Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, Moore MA, Asch AS.

Blood. 1994 Jul 1;84(1):10-9.

PMID:
7517203
31.

Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain.

Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M.

Science. 1993 Nov 26;262(5138):1436-40.

PMID:
7504322
32.

Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.

Asch AS, Silbiger S, Heimer E, Nachman RL.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1208-17.

PMID:
1371676
33.

Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.

Asch AS, Tepler J, Silbiger S, Nachman RL.

J Biol Chem. 1991 Jan 25;266(3):1740-5.

34.

Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium.

Konkle BA, Shapiro SS, Asch AS, Nachman RL.

J Biol Chem. 1990 Nov 15;265(32):19833-8.

35.
36.

Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.

Silverstein RL, Asch AS, Nachman RL.

J Clin Invest. 1989 Aug;84(2):546-52.

37.

Thrombospondin: phenomenology to function.

Asch AS, Nachman RL.

Prog Hemost Thromb. 1989;9:157-76. Review.

PMID:
2464182
38.
39.

Isolation of the thrombospondin membrane receptor.

Asch AS, Barnwell J, Silverstein RL, Nachman RL.

J Clin Invest. 1987 Apr;79(4):1054-61.

40.

Human brain glial cells synthesize thrombospondin.

Asch AS, Leung LL, Shapiro J, Nachman RL.

Proc Natl Acad Sci U S A. 1986 May;83(9):2904-8.

41.

Decay-accelerating factor is present on cultured human umbilical vein endothelial cells.

Asch AS, Kinoshita T, Jaffe EA, Nussenzweig V.

J Exp Med. 1986 Jan 1;163(1):221-6.

42.

Supplemental Content

Support Center